Small bowel metastases in non-small cell lung cancer

Lung Cancer

Volumn 26, Issue 2, 1999, Pages 95-101

  Stenbygaard, Lars E ^a   Sørensen, Jens B ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

Autopsy; Non small cell lung cancer; Small bowel metastases

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; SMALL INTESTINE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DUODENAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; INTESTINE, SMALL; LUNG NEOPLASMS; MIDDLE AGED; PNEUMONECTOMY; PROGNOSIS;

EID: 0032695271     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(99)00075-6     Document Type: Article

References (22)

1. Shopland D.R., Eyre H.J., Pechacek T.F. Smoking-attributable cancer mortality in: is lung cancer now the leading cause of death among smokers in the United States? J. Natl. Cancer Inst. 83:1991;1142-1148.
2. Sørensen J.B., Olsen J.E. Prognostic implications of histopathologic subtyping in patients with surgically treated stage I or II adenocarcinoma of the lung. J. Thorac. Cardiovasc. Surg. 97:1984;245-251.
3. Stenbygaard L.E., Sørensen J.B., Olsen J.E. Metastatic pattern in adenocarcinoma of the lung. J. Thorac. Cardiovasc. Surg. 110:1995;1130-1135.
4. Anderson H., Lund B., Bach F., Thatcher N., Walling J., Hansen H.H. Single agent activity of weekly gemcitabine in advanced non-small cell lung cancer. A phase II study. J. Clin. Oncol. 12:1994;1821-1826.
5. Bach F., Vibe-Petersen J., Sørensen J.B., Dombernowsky P., Hansen H.H. Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung. Eur. J. Cancer. 26:1990;545.
6. Lund B., Ryberg M., Meidahl Petersen P., Anderson H., Thatcher N., Dombernowsky P. Phase II study of gemcitabine (2,2-diflourodeoxycytidine) given as twice-weekly schedule to previously untreated patients with non-small cell lung cancer. Ann. Oncol. 5:1994;852-853.
7. Sørensen J.B., Hansen H.H., Dombernowsky P., Bork E., Malmberg R., Aabo K., Bødker B., Hansen M. Chemotherapy for adenocarcinoma of the lung (WHO 3): a randomized study of vindesine versus lomustine, cyclophosphamide and methotrexate versus all four drugs. J. Clin. Oncol. 5:1987;1169-1177.
8. Sørensen J.B., Bach F., Dombernowsky P., Hansen H.H. Phase II study of teniposide in adenocarcinoma of the lung. Cancer Chemother. Pharmacol. 27:1991;487-489.
9. Sørensen J.B., Stenbygaard L., Drivsholm L., Dombernowsky P., Hansen H.H. Phase II study of 4-iodo-deoxydoxorubicin in nonresectable non-small cell lung cancer. Cancer Chemother. Pharmacol. 32:1993;399-402.
10. Sørensen J.B., Nielsen A.L., Krarup M., Dombernowsky P., Hansen H.H. Phase II study of gemcitabine+vindesine in patients with previously untreated inoperable non-small cell lung cancer (NSCLC). Lung Cancer. 11(Suppl 1):1994;116.
11. Vibe-Petersen J., Bach F., Pedersen A.G., Smyth J., Hansen H.H. A phase II trial of TCNU in patients with squamous, adeno and large-cell carcinoma of the lung. Eur. J. Cancer Clin. Oncol. 25:1989;1881-1882.
12. Sørensen J.B., Badsberg J.H., Olsen J.E. Prognostic factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients. Cancer Res. 49:1989;5748-5754.
13. Mountain C.F. The new international system for staging of lung cancer. Chest (Suppl.). 89:1986;225S-233S.
14. Histological Typing of Lung Tumors. 2nd ed:1981;World Health Organisation, Geneva. pp. 1-41.
15. Handbook for Reporting Results of Cancer Treatment. 1979;World Health Organisation, Geneva.
16. McNeill P.M., Wagman L.D., Neifeld J.P. Small bowel metastases from primary carcinoma of the lung. Cancer. 59:1987;1486-1489.
17. Washington K., McDonagh D. Secondary tumors of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey. Modern Pathol. 8(4):1995;427-433.
18. Leidich R.B., Rudolf L.E. Small bowel perforation secundary to metastatic lung carcinoma. Ann. Surg. 193:1981;67-69.
19. Pairolero P.C., Williams D.E., Bergstrahl E.J., Piehler J.M., Bernat P.E. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann. Thorac. Surg. 38:1984;331-338.
20. Feld R., Rubinstein L.V., Weisenberger T.H. Sites of recurrence in resected stage I Non-Small-Cell Lung Cancer: a guide for future studies. J. Clin. Oncol. 12:1984;1352-1358.
21. Anonymous. Editorial. Research after death, Lancet 1994;344:1517-1518.
22. Lee P.N. Comparison of autopsy, clinical, and death certificate diagnosis with particular reference to lung cancer. A review of published data. APMIS Suppl. 45:1994;1-42.